Evidence map›Paper›PMID 32336846›Full record

ArticleAtomic spectroscopy2018

Trace Metals Screening Process of Devices Used for the Collection, Analysis, and Storage of Biological Specimens.

Cynthia D Ward, Reba J Williams, Katelyn Mullenix, Kristy Syhapanha, Robert L Jones, Kathleen Caldwell

Abstract read
In one paragraph

Article in Atomic spectroscopy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Cynthia D WardCenters for Disease Control and Prevention, National Center for Environmental Health, Division of Laboratory Sciences, Inorganic & Radiation Analytical Toxicology Branch, 4770 Buford Highway NE MS F-50, Atlanta, GA 30341-3717, USA.
Reba J WilliamsCenters for Disease Control and Prevention, National Center for Environmental Health, Division of Laboratory Sciences, Inorganic & Radiation Analytical Toxicology Branch, 4770 Buford Highway NE MS F-50, Atlanta, GA 30341-3717, USA.
Katelyn MullenixOak Ridge Institute for Science and Education, 4770 Buford Highway NE MS F-50, Atlanta, GA 30341-3717, USA.
Kristy SyhapanhaOak Ridge Institute for Science and Education, 4770 Buford Highway NE MS F-50, Atlanta, GA 30341-3717, USA.
Robert L JonesCenters for Disease Control and Prevention, National Center for Environmental Health, Division of Laboratory Sciences, Inorganic & Radiation Analytical Toxicology Branch, 4770 Buford Highway NE MS F-50, Atlanta, GA 30341-3717, USA.
Kathleen CaldwellCenters for Disease Control and Prevention, National Center for Environmental Health, Division of Laboratory Sciences, Inorganic & Radiation Analytical Toxicology Branch, 4770 Buford Highway NE MS F-50, Atlanta, GA 30341-3717, USA.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

The Centers for Disease Control and Prevention's (CDC) Environmental Health Laboratory uses modified versions of inductively coupled plasma mass spectrometry (ICP-MS) analytical methods to quantify metals contamination present in items that will come into contact with patient samples during the pre-analytical, analytical, and post-analytical stages. This lot screening process allows us to reduce the likelihood of introducing contamination which can lead to falsely elevated results. This is particularly important when looking at biomonitoring levels in humans which tend to be near the limit of detection of many methods. The fundamental requirements for a lot screening program in terms of facilities and processes are presented along with a discussion of sample preparation techniques used for lot screening. The criteria used to evaluate the lot screening data to determine the acceptability of a particular manufacturing lot is presented as well. As a result of lot testing, unsuitable manufactured lots are identified and excluded from use.

Identifiers

PMID32336846
PMCPMC7181901

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.